Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
JCO Precision Oncology|September 22, 2023
Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept StudyJamila Mammadova, Christelle Colin-Leitzinger, Diep Nguyen, et al.
Open Heart|January 19, 2018
Rates and risk of arrhythmias in cancer survivors with chemotherapy-induced cardiomyopathy compared with patients with other cardiomyopathiesMichael G Fradley, Federico Viganego, Kevin Kip, et al.
The Oncologist|April 19, 2019
A Phase II Trial of Selinexor (KPT-330) for Metastatic Triple-Negative Breast CancerMichael Shafique, Roohi Ismail-Khan, Martine Extermann, et al.
Breast Cancer Research and Treatment|January 8, 2022
Barriers and facilitators to taking CDK4/6 inhibitors among patients with metastatic breast cancer: a qualitative studyClaire C Conley, McKenzie McIntyre, Nicole A Pensak, et al.
American Journal of Surgery|July 2, 2013
Comparison of breast magnetic resonance imaging clinical tumor size with pathologic tumor size in patients status post-neoadjuvant chemotherapyMindy Williams, Jennifer Eatrides, Jongphil Kim, et al.
Cancer Control : Journal of the Moffitt Cancer Center|August 4, 2006
Overall and progression-free survival in metastatic melanoma: analysis of a single-institution databaseM Aleem Khan, Stephanie Andrews, Roohi Ismail-Khan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2012
Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancerPamela N Munster, Amy P Moore, Roohi Ismail-Khan, et al.
Oncology Reviews|August 8, 2017
Developing a Comprehensive Cardio-Oncology Program at a Cancer Institute: The Moffitt Cancer Center ExperienceMichael G Fradley, Allen C Brown, Bernadette Shields, et al.
Circulation. Genomic and Precision Medicine|April 26, 2021
Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart AssociationTochi M Okwuosa, Alicia Morgans, June-Wha Rhee, et al.
Cancer|February 27, 2008
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or olderGeorge R Simon, Martine Extermann, Alberto Chiappori, et al.
Pageof 5